Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe

Dupilumab, a human monoclonal antibody against interleukin‐4 receptor alpha, has demonstrated efficacy and an acceptable safety profile in adult and pediatric patients with moderate‐to‐severe atopic dermatitis (AD) and other type 2 inflammatory diseases. Dupilumab is available in 200‐ and 300‐mg str...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Yehuda Z., Zhang, Xiaojia, Xia, Binfeng, Kosloski, Matthew P., Kamal, Mohamed A., Davis, John D., Kanamaluru, Vanaja, Xu, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311711/
https://www.ncbi.nlm.nih.gov/pubmed/35278283
http://dx.doi.org/10.1002/cpdd.1073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311711/
https://www.ncbi.nlm.nih.gov/pubmed/35278283
http://dx.doi.org/10.1002/cpdd.1073

Ejemplares similares